Previous close | 1,917.00 |
Open | 1,908.00 |
Bid | 1,736.00 x 1700 |
Ask | 1,900.00 x 3400 |
Day's range | 1,908.00 - 1,908.00 |
52-week range | 1,600.00 - 2,049.00 |
Volume | |
Avg. volume | 58 |
Market cap | 3.319T |
Beta (5Y monthly) | 0.74 |
PE ratio (TTM) | 33.11 |
EPS (TTM) | 57.62 |
Earnings date | 18 Jul 2024 - 22 Jul 2024 |
Forward dividend & yield | 40.66 (2.13%) |
Ex-dividend date | 15 Jul 2024 |
1y target est | N/A |
In the closing of the recent trading day, Abbott (ABT) stood at $105.49, denoting a +0.18% change from the preceding trading day.
Banking on the successful execution of its Branded Generic operating model, Abbott's (ABT) EPD is well-positioned for sustained growth in many of the growing pharmaceutical markets.
Abbott Laboratories, BP, Gilead Sciences, Smith-Midland and Crimson Wine are included in this Analyst Blog.